ArticleFrontiers in medicine2025
Deep learning for enhanced prediction of diabetic retinopathy: a comparative study on the diabetes complications data set.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A machine learning model for diabetic retinopathy risk stratification using routine blood and urine parameters: insights into kidney-eye crosstalk.Frontiers in endocrinology · 2026Article
- The Role of Artificial Intelligence in the Diagnosis and Management of Diabetic Retinopathy.Journal of clinical medicine · 2025Review
- CRAB-RSS: development and validation of a single-center risk stratification model for carbapenem-resistantFrontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic retinopathy (DR) screening faces critical challenges in early detection due to its asymptomatic onset and the limitations of conventional prediction models. While existing studies predominantly focus on image-based AI diagnosis, there is a pressing need for accurate risk prediction using structured clinical data. The purpose of this study was to develop, compare, and validate models for predicting retinopathy in diabetic patients via five traditional statistical models and deep learning models. Methods: On the basis of 3,000 data points from the Diabetes Complications Data Set of the National Center for Population Health Sciences Data, the differences in the characteristics of patients with diabetes mellitus and diabetes combined with retinopathy were statistically analyzed using SPSS software. Five traditional machine learning models and a model based on deep neural networks (DNNs) were used to train models to assess retinopathy in diabetic patients. Results: Deep learning-based prediction models outperformed traditional machine learning models, namely logistic regression, decision tree, naive Bayes, random forest, and support vector machine, on all the datasets and performed better in predicting retinopathy in diabetic patients (accuracy, 0.778 vs. 0.753, 0.630, 0.718, 0.758, 0.776, respectively; F1 score, 0.776 vs. 0.751, 0.602, 0.724, 0.755, 0.776, respectively; AUC, 0.833 vs. 0.822, 0.631, 0.769, 0.829, 0.831, respectively). To enhance the interpretability of the deep learning model, SHAP analysis was employed to assess feature importance and provide insights into the key drivers of retinopathy prediction. Conclusion: Deep learning models can accurately predict retinopathy in diabetic patients. The findings of this study can be used for prevention and monitoring by allocating resources to high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.